drug development

Johnson and Johnson to use Artificial Intelligence to develop drugs  

Johnson and Johnson(J&J) in association with BenevolentAI, are all set to release drugs that were developed with the use of Artificial Intelligence (AI) technology. The latter achieved this after acquiring London based Janssen, a business subsidiary of J&J that will use multiple drug candidates to treat dreaded diseases. It is a known fact that some […]

Share this page